We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pathobiological Determinants of Atherosclerosis in Youth (PDAY)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00005679
First Posted: May 26, 2000
Last Update Posted: February 18, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
  Purpose
To conduct a multicenter prevalence survey for characterizing pathologically the extent of atherosclerosis in the aortas and coronary arteries of young persons dying from accidental causes, suicide, or homicide.

Condition
Cardiovascular Diseases Atherosclerosis Heart Diseases Coronary Disease Coronary Arteriosclerosis

Study Type: Observational

Resource links provided by NLM:


Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: June 1985
Study Completion Date: July 1993
Primary Completion Date: July 1993 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   15 Years to 34 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria
No eligibility criteria
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00005679


Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
OverallOfficial: Arthur Chandler Augusta University
OverallOfficial: J. Cornhill Ohio State University
OverallOfficial: Asaad Daoud Albany Medical College
OverallOfficial: Morton Friedman Ohio State University
OverallOfficial: Steffen Gay University of Alabama at Birmingham
OverallOfficial: James Hixson Southwest Foundation for Biomedical Research
OverallOfficial: Singanallur Jagannathan West Virginia University Medical Center
OverallOfficial: C. McMahan University of Texas
OverallOfficial: Wolfgang Mergner University of Maryland
OverallOfficial: Edward Miller University of Alabama at Birmingham
OverallOfficial: Stanley Radio University of Nebraska
OverallOfficial: Dennis Reichebach University of Washington
OverallOfficial: Abel Robertson University of Illinois at Chicago
OverallOfficial: Louis Smith Baylor College of Medicine
OverallOfficial: Jack Strong Louisiana State University Medical Center
OverallOfficial: Renu Virmani Vanderbilt University School of Medicine
OverallOfficial: Robert Wissler University of Chicago
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00005679     History of Changes
Other Study ID Numbers: 1049
R10HL033772 ( U.S. NIH Grant/Contract )
First Submitted: May 25, 2000
First Posted: May 26, 2000
Last Update Posted: February 18, 2016
Last Verified: January 2008

Additional relevant MeSH terms:
Cardiovascular Diseases
Heart Diseases
Atherosclerosis
Coronary Disease
Coronary Artery Disease
Arteriosclerosis
Myocardial Ischemia
Arterial Occlusive Diseases
Vascular Diseases